← Back to headlines
Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound - WSJ
Novo Nordisk Shares Plunge After Obesity Drug Fails to Beat Zepbound WSJ
23 Feb, 16:44 — 23 Feb, 16:44
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Understanding Emotional Intelligence and Its Importance for Success
10m ago
Christina Applegate Opens Up About Her Battle with Multiple Sclerosis
14m ago
Indian Comedian Tanmay Bhat Discusses Weight Loss Journey and GLP-1 Drugs
15m ago
Relatives Allege Misdiagnosis in Death of 46-Year-Old Sailor in Skyros
17m ago